tirzepatide non responders Doctor, I'm not losing weight on the GLP1” 🛑👇🏻 When When Weight-Loss Drugs Don't Work

Some research suggests that GLP-1 receptor agonists may have effects on adipose tissue metabolism and adipokine profiles, though these findings remain preliminary and require further investigation

Recent statistics indicate that nearly 12 percent of patients with cardiovascular disease may have elevated remnant lipid levels, even after achieving their LDL targets, suggesting hidden risks that need attention

Additionally, some individuals may have genetic variations in AMPK or NNMT expression that reduce responsiveness to these compounds, though this is less common

Amor-Salamanca, A

its use outside clinical trials is illegal, medically dangerous, and prohibited under WADA anti-doping rules